News & Releases

Intact Genomics (IG®) Selected for NIH SEED Company Showcase at RESI Conference 2025

We are thrilled to announce that Intact Genomics has been selected by the prestigious NIH SEED Company Showcase Program to...

Intact Genomics Announces Launch of Innovative Products for RPA Technology

November 25, 2024 â€“ Intact Genomics (IG®), a leading molecular biology reagent company, is proud to announce the launch of three...

Intact Genomics Attended the Next Generation Dx Summit in Washington DC on August 19-21

Our CEO, Dr. Chengcang Charles Wu, attended the 16th annual Next Generation Dx Summit (https://www.nextgenerationdx.com) at the Capital Hilton in Washington D.C. where he had a post...

Intact Genomics Exhibited at 2024 SIVB World Congress on June 8-12, 2024

At the SIVB World Congress, Intact Genomics proudly showcased our new and existing products to hundreds of event attendees from around the world. Our Sales Director, Matthew...

Intact Genomics Stands Strong for Research

In February, we welcomed our local news station for an insightful discussion on the recent NIH funding cuts and their...

New Publications from Intact Genomics Scientists

Intact Genomics (IG®) scientists and collaborators published 3 papers in peer-reviewed journals recently. For further details, click the links below...

Intact Genomics hosted site visits from local high school Spark and Center for Advanced Professional Studies (CAPS) programs

On November 30 and Dec 1, 2023, Intact Genomics (IG) had the pleasure of hosting high school students from St....

Intact Genomics Receives ISO 13485 Certification

St. Louis, MO. (August 7, 2023) – Intact Genomics (IG®), a leading provider of cutting-edge molecular biology products and services,...

Intact Genomics Presented at the 2023 ASP (The American Society of Pharmacognosy) Annual Meeting in Rockville, MD on July 24, 2023

Intact Genomics CEO, Dr. Chengcang Charles Wu, gave a contributed talk of “Fungal Artificial Chromosome Pipeline Enables the Discovery of...